{"id":1305,"date":"2026-07-02T05:39:15","date_gmt":"2026-07-02T05:39:15","guid":{"rendered":"https:\/\/blog.franke-ip.com\/en\/?p=1305"},"modified":"2026-07-02T20:15:34","modified_gmt":"2026-07-02T20:15:34","slug":"can-a-research-hub-be-rescued-on-credit-debt-taxes-and-red-tape-from-a-startup-perspective","status":"publish","type":"post","link":"https:\/\/blog.franke-ip.com\/en\/can-a-research-hub-be-rescued-on-credit-debt-taxes-and-red-tape-from-a-startup-perspective\/","title":{"rendered":"Can a Research Hub Be Rescued on Credit? Debt, Taxes and Red Tape from a Startup Perspective"},"content":{"rendered":"\n

A follow-up to “Is Germany Falling Behind? What 125 Years of Nobel Prizes Reveal About Its Research Landscape<\/a>“<\/em><\/p>\n\n\n

\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n

The previous article closed with a finding that can be summed up in a single sentence: Germany is not losing ground because it does too little research, but because others scale faster, bigger and more deliberately \u2014 and because the path from an idea to a granted IP right is too long here. That leads almost inevitably to the economic-policy question now under intense debate: can the gap be closed with money? Specifically \u2014 can Germany strengthen its position as a research hub by taking on new debt and investing massively in research and development? And how does that relate to the parallel debates over higher taxes and levies, over bureaucracy, and over the conditions for new company formation?<\/p>\n\n\n\n

For a startup, this is no academic question. Where research is done and financed, the inventions arise that become tomorrow’s patents and marketable products. We work through the debate along four questions and close with a conclusion for IP practice.<\/p>\n\n\n\n

1. The fiscal headroom: how much “reserve” is there in the first place?<\/h2>\n\n\n\n

First, the good news for anyone counting on debt-financed investment. Measured by the internationally comparable Maastricht definition, Germany’s debt-to-GDP ratio stood at 63.5 percent in 2025 \u2014 around \u20ac2.84 trillion. That is comfortable in the EU context: the EU average rose to 81.7 percent in 2025, France stood at 115.6 percent, Italy at 137.1 percent and Greece at 146.1 percent. Only a handful of states, such as Estonia (24.1 percent), are better positioned than Germany. Germany’s top rating and low refinancing costs confirm this headroom \u2014 while France, for instance, was downgraded in September 2025 and pays markedly higher interest.<\/p>\n\n\n\n

That reserve is, however, being deployed at high speed. With the constitutional amendment of March 2025, Germany’s Schuldenbremse<\/em> (constitutional debt brake) was opened up in two areas: defence spending above a threshold was largely exempted from the borrowing limit, and a credit-financed “infrastructure special fund” (Sonderverm\u00f6gen<\/em>) of \u20ac500 billion in total was created (\u20ac300 billion for the federal government, \u20ac100 billion for the states and municipalities, \u20ac100 billion for the Climate and Transformation Fund). It is important not to misread the label: these special funds are genuine debt and are counted in the official ratio \u2014 they are “assets” in name only. Projections see the debt ratio climbing to somewhere between 70 and over 100 percent in the coming years, depending on growth and inflation.<\/p>\n\n\n\n

Two things follow for the research hub. First, fiscal room for additional investment does exist and is tolerated by the capital markets. Second, it is finite, already largely earmarked for defence and infrastructure, and the real long-term liabilities \u2014 pensions and civil-servant retirement obligations \u2014 loom as implicit commitments that are not even captured in the official ratio. Anyone wishing to fund the research hub with new borrowing is therefore competing with other claims for a limited and shrinking buffer.<\/p>\n\n\n\n

2. Money is rarely the real bottleneck<\/h2>\n\n\n\n

The central insight of the Nobel Prize article was that Germany does not fail on research intensity. The latest figures bear this out: in 2024, spending on research and development rose to \u20ac137.1 billion, a share of 3.17 percent of GDP and thus the highest reading since the series began in 1995. Among the large EU economies Germany is out in front, comfortably clearing the European three-percent target.<\/p>\n\n\n\n

The national target of 3.5 percent was missed by 2025 and pushed back to 2030 by the federal and state governments in December 2025 \u2014 but the decisive point lies elsewhere: roughly two thirds of R&D spending (about \u20ac92.5 billion in 2024) is borne by the private sector, not the state. The 3.5-percent target is simply unreachable without private investment. Additional public debt can therefore make a contribution \u2014 for computing infrastructure, non-university top-tier research, or equity capital \u2014 but it does not replace corporate innovation budgets, and it does not address the structural weaknesses: bureaucracy, the translation gap, skilled labour, economies of scale.<\/p>\n\n\n\n

The direction of travel is the real warning sign. While real R&D spending in the United States grew in 2024, in Germany it slipped slightly. A public investment programme can cushion this trend \u2014 but only if it actually flows into productive, location-strengthening uses rather than into consumptive spending that burdens debt sustainability without raising innovative capacity. Debt is a lever, not an end in itself; its effect on the research hub depends entirely on what it is spent on.<\/p>\n\n\n\n

3. Taxes and levies: the underrated location factor<\/h2>\n\n\n\n

If money is not the bottleneck, the framework conditions move to the fore \u2014 and here Germany fares poorly by international comparison. The tax-and-contribution ratio (taxes and social contributions relative to GDP) hit a historic high of around 42 percent in 2025. On corporate taxation, the headline combined burden on corporations exceeds 30 percent, against an OECD average of about 24 percent and an EU average of roughly 21 percent; the effective rate is just under 27 percent. In the Tax Foundation’s 2025 International Tax Competitiveness Index, Germany ranks 20th of 38 OECD countries and has the fourth-highest corporate tax rate. The burden on labour is high too: the top rate of income tax reaches 47.5 percent including the solidarity surcharge, and the tax wedge on labour is the second-highest in the OECD after Belgium.<\/p>\n\n\n\n

For research-intensive startups this matters twice over. On the one hand, high non-wage labour costs make precisely those highly qualified positions expensive that form the core of a deep-tech or biotech team. On the other, the taxation of equity stakes and exits helps determine whether internationally mobile founders and investors choose the location at all.<\/p>\n\n\n\n

Policymakers have recognised the need to act. For the years 2025 to 2027, an “investment booster” was adopted, offering 30 percent declining-balance depreciation on equipment investments; from 2028, the K\u00f6rperschaftsteuer<\/em> (corporate income tax) is to fall in five annual steps from 15 to 10 percent. Whether these reliefs are sufficient and arrive in time is an open question \u2014 but the direction is right. In fairness, it should be noted that the high tax-and-contribution ratio also finances a capable system of public goods, and that the effective burden on investment sits below the headline rate thanks to generous depreciation rules. For the location decision of a mobile founder, however, what counts is the overall signal \u2014 and at present that signal is unfavourable.<\/p>\n\n\n\n

4. Do debates about higher taxes harm the research hub?<\/h2>\n\n\n\n

This is precisely where the political controversy sits. Alongside the relief plans, there are proposals for higher burdens \u2014 for instance to tighten the Erbschaftsteuer<\/em> (inheritance and gift tax) or to reintroduce a wealth tax. Proponents argue on grounds of distributional fairness and of the state’s financing needs in an ageing society. The other side \u2014 including business associations and family-owned firms \u2014 warns that tightening inheritance tax would considerably complicate succession in mid-sized companies and thereby endanger long-established structures.<\/p>\n\n\n\n

For the research hub and for startups, the effect of such debates is ambivalent, and it deserves a sober look. What matters economically is less the individual measure than the expectations effect: location decisions, company formations and growth financing are long-term and react sensitively to uncertainty about the future tax burden. When higher taxation of capital, wealth or exits is discussed without a clear framework in sight, the uncertainty alone can make investors more cautious and deter internationally mobile founders \u2014 precisely in an environment where competition for talent and venture capital is fierce and where Germany already lags on the availability of capital (see Section 6).<\/p>\n\n\n\n

At the same time, it would be simplistic to dismiss every tax increase as damaging to the location per se. What is decisive is the concrete design: a measure that burdens broad incomes and dampens work incentives operates differently from a targeted rule with reliable exemptions for entrepreneurial capital. From the specific vantage point of innovative startups, though, the finding can be stated clearly: what these companies need most is predictability and a competitive treatment of equity participation and exits. Debates that undermine that predictability are riskier for the research and founding hub than their fiscal revenue would justify \u2014 regardless of how one assesses them on distributional grounds.<\/p>\n\n\n\n

5. Bureaucracy and barriers to founding<\/h2>\n\n\n\n

The Nobel Prize article named bureaucracy and slow procedures as a structural weakness of the location. For new companies this is felt directly: drawn-out formation and permitting processes, burdensome reporting and documentation duties, a tax code whose complexity overwhelms small teams, and cumbersome immigration procedures for international skilled workers. Every hour a founding team spends on administration rather than product development lengthens the path to its first protectable invention.<\/p>\n\n\n\n

Especially critical is the much-cited translation gap \u2014 the transition from basic research to a marketable, patentable application. It is not merely a matter of money but also of process: university spin-offs frequently founder on unclear rules governing intellectual property, on slow equity decisions by the institutions, and on missing structures for technology transfer. Cutting red tape is therefore no sideshow but one of the most effective and, at the same time, most budget-friendly levers \u2014 unlike additional debt, it costs the state nothing and improves conditions immediately.<\/p>\n\n\n\n

6. What startups need from the state<\/h2>\n\n\n\n

Distilling the perspective of innovative startups yields a list of priorities that only partly concerns money:<\/p>\n\n\n\n

Venture capital in the growth phase.<\/strong> Germany’s financing gap is structural: measured against GDP, Germany has recently invested a fraction of what flows into US startups, and the market has historically been bank-financed rather than equity-oriented. The WIN initiative (Growth and Innovation Capital for Germany), launched in 2024, aims to mobilise \u20ac12 billion by 2030 initially \u2014 and, under the 2025 coalition’s plans, more than \u20ac25 billion; by the end of 2025, around \u20ac2.64 billion had been committed. Flanking this, a reform of the investment ordinance (Anlageverordnung<\/em>) in early 2025 widened the scope for insurers and pension funds to hold risk capital. Here the state is on the right track but must deliver \u2014 early voices are already warning that the initiative is running out of steam.<\/p>\n\n\n\n

Non-dilutive innovation funding.<\/strong> The Forschungszulage<\/em> (Germany’s statutory research and development tax allowance) is perhaps the most underrated lever. Since its introduction in 2020, and following expansions through the Growth Opportunities Act (Wachstumschancengesetz<\/em>, 2024) and the tax investment programme (2025), it supports research-active companies with \u2014 for SMEs \u2014 35 percent on an assessment base of up to \u20ac12 million per year, i.e. a maximum of roughly \u20ac4.2 million. It is a legal entitlement rather than a competitive procedure, is paid out in cash where there is no tax liability, and does not dilute equity. For young, still loss-making companies, that is cash on the cost side \u2014 and the underlying project scoping simultaneously creates substance in investor due diligence.<\/p>\n\n\n\n

Predictable, competitive taxation<\/strong> \u2014 in particular of employee equity participation and exits (see Section 4).<\/p>\n\n\n\n

Lean procedures and a genuine welcome culture<\/strong> for international top talent, faster spin-offs, functioning technology transfer, and the closing of the translation gap (see Section 5).<\/p>\n\n\n\n

The ordering is telling: of these four points, only the first is primarily a question of money \u2014 and even there it is less about state debt than about mobilising private capital. The other three are matters of reform, not of spending.<\/p>\n\n\n\n

7. Conclusion for IP practice<\/h2>\n\n\n\n

The answer to the opening question is therefore this: more debt and more R&D spending can support the research hub, but they are neither sufficient nor the most effective lever. In Germany, money is rarely the bottleneck; speed, the tax burden, the availability of capital in the growth phase, and the procedures at the interface between research and commercialisation are. A debt-financed investment programme delivers only when accompanied by structural reform \u2014 otherwise it consumes a limited fiscal buffer without raising innovative capacity.<\/p>\n\n\n\n

For clients and IP strategists, this yields concrete points of connection:<\/p>\n\n\n\n